ENTITY
CSPC Pharmaceutical

CSPC Pharmaceutical (1093 HK)

519
Analysis
Health Care • China
CSPC Pharmaceutical Group Limited is a prominent Chinese pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products, including innovative drugs and bulk drugs. Its key products include innovative drugs for nervous system diseases, oncology, anti-infectives, and cardiovascular diseases, as well as bulk products like vitamin C, antibiotics, and caffeine. The company was formally established in 1997 and is headquartered in Shijiazhuang, Hebei Province, China.
more
Exchange Announcement • 08 Oct 2026 18:22

Voluntary Announcement - Data From Phase I Clinical Study Of Sys6002 As Monotherapy For The Treatment Of Advanced Cervical Cancer Presented As A Rapid Oral Presentation At The 2026 Annual Global Meeting Of The International Gynecologic Cancer Society (Igcs 2026)

Exchange Announcement • 05 Oct 2026 18:50

Voluntary Announcement - Latest Updates From 8 Clinical Trials To Be Presented At The Esmo Congress 2026

Exchange Announcement • 30 Sep 2026 20:06

Voluntary Announcement - Results Of Phase Iii Clinical Study Of Efmedaglutide Alfa Injection In Combination With Metformin In Chinese Adult Patients With Type 2 Diabetes Mellitus Presented In A Short Oral Discussion At The 62nd Annual Meeting Of The European Association For The Study Of Diabetes (Easd 2026)

Exchange Announcement • 29 Sep 2026 18:03

Voluntary Announcement - Phase Ib Clinical Trial Of Jmt206 Injection For Weight Management In Adult Patients With Overweight Or Obesity Officially Initiated At The First Study Centre In China

Exchange Announcement • 29 Sep 2026 18:00

Voluntary Announcement - Recombinant Herpes Zoster Vaccine (Sys6052) Obtains Clinical Trial Approval In The U.S.

x